These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Receptors for insulin and insulin-like growth factor-1 and insulin receptor substrate-1 mediate pathways that regulate islet function. Kulkarni RN Biochem Soc Trans; 2002 Apr; 30(2):317-22. PubMed ID: 12023872 [TBL] [Abstract][Full Text] [Related]
4. Pancreatic beta-cell growth and survival--a role in obesity-linked type 2 diabetes? Lingohr MK; Buettner R; Rhodes CJ Trends Mol Med; 2002 Aug; 8(8):375-84. PubMed ID: 12127723 [TBL] [Abstract][Full Text] [Related]
5. Deletion of SOCS7 leads to enhanced insulin action and enlarged islets of Langerhans. Banks AS; Li J; McKeag L; Hribal ML; Kashiwada M; Accili D; Rothman PB J Clin Invest; 2005 Sep; 115(9):2462-71. PubMed ID: 16127460 [TBL] [Abstract][Full Text] [Related]
6. Alteration in insulin action: role of IRS-1 serine phosphorylation in the retroregulation of insulin signalling. Tanti JF; Gual P; Grémeaux T; Gonzalez T; Barrès R; Le Marchand-Brustel Y Ann Endocrinol (Paris); 2004 Feb; 65(1):43-8. PubMed ID: 15122091 [TBL] [Abstract][Full Text] [Related]
7. Apoptosis in the beta cells: cause or consequence of insulin secretion defect in diabetes? Sesti G Ann Med; 2002; 34(6):444-50. PubMed ID: 12523500 [TBL] [Abstract][Full Text] [Related]
13. Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes. Fernández AM; Kim JK; Yakar S; Dupont J; Hernandez-Sanchez C; Castle AL; Filmore J; Shulman GI; Le Roith D Genes Dev; 2001 Aug; 15(15):1926-34. PubMed ID: 11485987 [TBL] [Abstract][Full Text] [Related]
14. Knockout models are useful tools to dissect the pathophysiology and genetics of insulin resistance. Mauvais-Jarvis F; Kulkarni RN; Kahn CR Clin Endocrinol (Oxf); 2002 Jul; 57(1):1-9. PubMed ID: 12100063 [TBL] [Abstract][Full Text] [Related]
15. Tissue-specificity of insulin action and resistance. Benito M Arch Physiol Biochem; 2011 Jul; 117(3):96-104. PubMed ID: 21506723 [TBL] [Abstract][Full Text] [Related]
16. Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes. Lin X; Taguchi A; Park S; Kushner JA; Li F; Li Y; White MF J Clin Invest; 2004 Oct; 114(7):908-16. PubMed ID: 15467829 [TBL] [Abstract][Full Text] [Related]
17. A model to explore the interaction between muscle insulin resistance and beta-cell dysfunction in the development of type 2 diabetes. Mauvais-Jarvis F; Virkamaki A; Michael MD; Winnay JN; Zisman A; Kulkarni RN; Kahn CR Diabetes; 2000 Dec; 49(12):2126-34. PubMed ID: 11118016 [TBL] [Abstract][Full Text] [Related]
18. Pancreatic deletion of insulin receptor substrate 2 reduces beta and alpha cell mass and impairs glucose homeostasis in mice. Cantley J; Choudhury AI; Asare-Anane H; Selman C; Lingard S; Heffron H; Herrera P; Persaud SJ; Withers DJ Diabetologia; 2007 Jun; 50(6):1248-56. PubMed ID: 17393136 [TBL] [Abstract][Full Text] [Related]
19. Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. Kubota N; Tobe K; Terauchi Y; Eto K; Yamauchi T; Suzuki R; Tsubamoto Y; Komeda K; Nakano R; Miki H; Satoh S; Sekihara H; Sciacchitano S; Lesniak M; Aizawa S; Nagai R; Kimura S; Akanuma Y; Taylor SI; Kadowaki T Diabetes; 2000 Nov; 49(11):1880-9. PubMed ID: 11078455 [TBL] [Abstract][Full Text] [Related]
20. Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. Kido Y; Burks DJ; Withers D; Bruning JC; Kahn CR; White MF; Accili D J Clin Invest; 2000 Jan; 105(2):199-205. PubMed ID: 10642598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]